Revascularization for unprotected left main stem coronary artery stenosis: Stenting or surgery

被引：123

作者：

Taggart, David P. ^{[1
]}

Kaul, Sanjay ^{[2
]}

Boden, William E.

Ferguson, T. Bruce, Jr. ^{[3
,4
]}

Guyton, Robert A. ^{[6
]}

Mack, Michael J. ^{[7
]}

Sergeant, Paul T. ^{[9
]}

Shemin, Richard J. ^{[8
]}

Smith, Peter K. ^{[5
]}

Yusuf, Salim ^{[10
]}

机构：

[1] Univ Oxford, Dept Cardiac Surg, John Radcliffe Hosp, Oxford OX3 9DU, England

[2] Cedars Sinai Heart Inst, Div Cardiol, Los Angeles, CA USA

[3] NYU, Dept Cardiovasc Serv, Buffalo Gen & Mil fillmore Hosp, Sch Med & Biomed Sci, Buffalo, NY USA

[4] Eastern Carolina Univ, Div Cardiothorac & vasc surg, Brody Sch Med, Greenville, NC USA

[5] Duke Univ, Med Ctr, Div Cardiothorac Surg, Durham, NC USA

[6] Emory Univ, Sch Med, Div Cardiothorac Surg, Atlanta, GA 30322 USA

[7] Med City Hosp, Cardiopulm Res Sci Technol Inst, Dallas, TX USA

[8] Univ Calif Los Angeles, Div Cardiothorac Surg, Dept Surg, David Geffen Sch Med, Los Angeles, CA USA

[9] Univ Hosp Gasthuisberg, Dept Cardiac Surg, B-3000 Louvain, Belgium

[10] McMaster Univ, Populat Hlth Res Inst, Heart & Stroke Fdn, Hamilton, ON, Canada

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 09期

关键词：

D O I：

10.1016/j.jacc.2007.09.067

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

For coronary artery disease with unprotected left main stem (LMS) stenosis, coronary artery bypass grafting (CABG) is traditionally regarded as the "standard of care" because of its well-documented and durable survival advantage. There is now an increasing trend to use drug-eluting stents for LMS stenosis rather than CABG despite very little high-quality data to inform clinical practice. We herein: 1) evaluate the current evidence in support of the use of percutaneous revascularization for unprotected LMS; 2) assess the underlying justification for randomized controlled trials of stenting versus surgery for unprotected LMS; and 3) examine the optimum approach to informed consent. We conclude that CABG should indeed remain the preferred revascularization treatment in good surgical candidates with unprotected LMS stenosis.

引用

页码：885 / 892

页数：8

共 49 条

[41] Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265] [J].

Taggart, DP ;

Lees, B ;

Gray, A ;

Altman, DG ;

Flather, M ;

Channon, K .

TRIALS, 2006, 7 (1)

[42] Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery [J].

Takagi, T ;

Stankovic, G ;

Finci, L ;

Toutouzas, K ;

Chieffo, A ;

Spanos, V ;

Liistro, F ;

Briguori, C ;

Corvaja, N ;

Albero, R ;

Sivieri, G ;

Paloschi, R ;

Di Mario, C ;

Colombo, A .

CIRCULATION, 2002, 106 (06) :698-702

[43] Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients [J].

Tan, WA ;

Tamai, H ;

Park, SJ ;

Plokker, HWT ;

Nobuyoshi, M ;

Suzuki, T ;

Colombo, A ;

Macaya, C ;

Holmes, DR ;

Cohen, DJ ;

Whitlow, PL ;

Ellis, SG .

CIRCULATION, 2001, 104 (14) :1609-1614

[44] Narrative review: Drug-eluting stents for the management of restenosis: A critical appraisal of the evidence [J].

Tung, Roderick ;

Kaul, Sanjay ;

Diamond, George A. ;

Shah, Prediman K. .

ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :913-919

[45] Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era - An integrated clinical and angiographic analysis based on the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) and taxus-stent evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries [J].

Valgimigli, M ;

Malagutti, P ;

Rodriguez-Granillo, GA ;

Garcia-Garcia, HM ;

Polad, J ;

Tsuchida, K ;

Regar, E ;

Van der Giessen, WJ ;

de Jaegere, P ;

de Feyter, P ;

Serruys, PW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1530-1537

[46] Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease - Insights from the rapamycin-eluting and Taxus Stent evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH) [J].

Valgimigli, M ;

van Mieghem, CAG ;

Ong, ATL ;

Aoki, J ;

Granillo, GAR ;

McFadden, EP ;

Kappetein, AP ;

de Feyter, PJ ;

Smits, PC ;

Regar, E ;

Van der Giessen, WJ ;

Sianos, G ;

de Jaegere, P ;

Van Domburg, RT ;

Serruys, PW .

CIRCULATION, 2005, 111 (11) :1383-1389

[47] Off-pump coronary artery bypass surgery for critical left main stem disease: safety, efficacy and outcome [J].

Yeatman, M ;

Caputo, M ;

Ascione, R ;

Ciulli, F ;

Angelini, GD .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 19 (03) :239-244

[48] EFFECT OF CORONARY-ARTERY BYPASS GRAFT-SURGERY ON SURVIVAL - OVERVIEW OF 10-YEAR RESULTS FROM RANDOMIZED TRIALS BY THE CORONARY-ARTERY BYPASS GRAFT-SURGERY TRIALISTS COLLABORATION [J].

YUSUF, S ;

ZUCKER, D ;

PEDUZZI, P ;

FISHER, LD ;

TAKARO, T ;

KENNEDY, JW ;

DAVIS, K ;

KILLIP, T ;

PASSAMANI, E ;

NORRIS, R ;

MORRIS, C ;

MATHUR, V ;

VARNAUSKAS, E ;

CHALMERS, TC .

LANCET, 1994, 344 (8922) :563-570

[49] The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: One-year results from the Stent or Surgery (SoS) trial [J].

Zhang, Zefeng ;

Mahoney, Elizabeth M. ;

Spertus, John A. ;

Booth, Jean ;

Nugara, Fiona ;

Kohn, Paul ;

Stables, Rodney H. ;

Weintraub, William S. .

AMERICAN HEART JOURNAL, 2006, 152 (06) :1153-1160

← 1 2 3 4 5 →